During the past decade, Boeson Research HLN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Boeson Research HLN" are "Acute Treatment of Migraine" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "Boeson Research HLN" in a lesser frequency.

Most popular intervention types in "Boeson Research HLN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Matching placebo" (1 trials), "Rimegepant / BHV3000" (1 trials) and "Rimegepant/BHV3000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boeson Research HLN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Boeson Research HLN". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Boeson Research HLN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boeson Research HLN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".